PROTO SCRIPT PHARMACEUTICAL CORP Net Cash Provided by (Used in) Financing Activities, Continuing Operations
PROTO SCRIPT PHARMACEUTICAL CORP reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $362.09 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was $24.90K, a 18.37% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $59.98K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $277.21K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was -$30.94K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was -$34.46K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was -$54.07K.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | $24.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-08 | $84.88K derived: sum of 2 quarters · filed 2018-03-08 | $362.09K 10-Q · filed 2018-03-08 | $331.15K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $59.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | $337.19K 10-Q · filed 2018-01-17 | $306.24K derived: sum of 3 quarters · filed 2018-01-17 | $336.75K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $277.21K 10-Q · filed 2017-11-22 | $246.27K derived: sum of 2 quarters · filed 2017-11-22 | $276.77K derived: sum of 3 quarters · filed 2018-03-08 | $258.14K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | -$30.94K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | -$435.00 derived: sum of 2 quarters · filed 2018-03-08 | -$19.07K derived: sum of 3 quarters · filed 2018-03-08 | -$34.46K 10-K/A · filed 2017-10-19 |
| 2016-09-30 | $30.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-08 | $11.88K derived: sum of 2 quarters · filed 2018-03-08 | -$3.52K 10-Q · filed 2018-03-08 | |
| 2016-06-30 | -$18.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | -$34.03K 10-Q · filed 2018-01-17 | ||
| 2016-03-31 | -$15.39K 10-Q · filed 2017-11-22 | |||
| 2015-12-31 | -$54.07K 10-K/A · filed 2017-10-19 |